2nd Annual Innovations in Dermatology Spring


Hilton Scottsdale
Scottsdale, Arizona

April 27, 2022 – April 30, 2022

hybrid logo





Abstract submission is now open.

Submission Close Date: Friday, March 11, 2022

We invite all registered meeting attendees to submit abstracts for poster presentation on their latest research on acne & rosacea, medical dermatology, atopic dermatitis, psoriasis, pediatric dermatology, cutaneous malignancies, aesthetics and skin of color. A list of abstracts will be selected as oral presentation and/or poster display during the conference.

At least one (1) author must be registered for the in-person meeting to have their abstracts considered for oral presentation and/or poster display. All submissions accepted for oral presentation must also create a poster for display.

All accepted abstracts will be included on our Innovations in Dermatology Virtual Platform as well as being displayed at the Innovations in Dermatology Spring Conference, April 27-30, 2022 at the Hilton Scottsdale in Scottsdale, AZ.

All accepted abstracts will be included as an Abstract Compendium supplement to be distributed with the print version of Cutis, a peer reviewed and INDEXED in Medicus/MEDLINE journal.

In addition, approved abstracts will also be submitted and indexed through our partner brand Read by QxMD. The platform drives awareness, dissemination and engagement with this content via the Read by QxMD platform, as an educational tactic to drive CQI. ‘Read’ works on iPhone, iPad, Android smartphones & tablets and any web-enabled device (including desktops), and uses channels such as mobile, email and push notification to connect with our global community of healthcare providers and researchers.

Download the App:

apple app store

If you are returning to complete or check the status of your submission, please sign-in using your email address and password.

Abstract Formatting and Content Guidelines

*You must be registered for the meeting to have your abstract considered for a presentation.

  • Language: English
  • Authors: full last name, first name, affiliations, degrees and contact information
  • Font: Arial
  • Maximum of 3000 characters, including spaces (not including the title, authors, or affiliations)
  • Maximum of 2 relevant tables or figures submitted as attachments (not embedded in the file): must be 600 dpi .jpg
  • References must be included as parenthetical in-text citations - first author, et al, journal and year - (Cruz D, et al. Blood 2012)
  • Full contact information of corresponding author (Please ensure that your email address is accurate, as all correspondence will be sent via email)
  • Abstract text should preferably be in a "structured abstract" form with sections marked Background, Objectives, Methods, Results, and Conclusions
  • Abstracts containing non-generic drug names or personal patient information, or reporting studies with unidentified chemical compounds, drugs, or materials, will not be accepted.
  • Please remember to include any relevant disclosures
  • Encore abstracts are accepted


Fee: No fee for abstracts not sponsored by industry; $495 per abstract for industry-sponsored abstracts.


View 2021 Innovations in Dermatology Abstracts published in Cutis:

2021 Abstracts published in Cutis are also indexed in PubMed

A portion of abstract fees will be donated to the Skin of Color Society and The Pediatric Dermatology Research Alliance (PeDRA).


The Skin of Color Society (SOCS) is a professional dermatologic organization established in 2004 by Susan C. Taylor, M.D. The society is dedicated to promoting awareness of and excellence within the special interest area of dermatology, skin of color. Individuals with skin of color are defined by the Society as those individuals of Asian, Hispanic/Latino, African, Native American, Pacific Island descent, and mixtures thereof.  SOCS mission is to promote awareness of and excellence within skin of color dermatology through research, education, mentorship and advocacy. We are committed to increasing diversity and inclusion in the field of dermatology to advance patient care. .


The Pediatric Dermatology Research Alliance (PeDRA) is a nonprofit research organization driven by the mission to create, inspire, and sustain research to prevent, treat, and cure childhood skin disease and vision of changing lives and healing children with skin disease through collaboration and discovery.  PeDRA has more than 550 active members across more than 180 institutions, deep connections with the patient community, and offers support to aspiring and established pediatric dermatology researchers through centralized research infrastructure, grants and fellowships funding, a growing education portfolio, and a robust annual conference.